Inhaled corticosteroids (ICS)

DRUG4 trials

Sponsors

Novartis, Parc de Salut Mar, Boehringer Ingelheim

Conditions

AsthmaAsthma ExacerbationAsthma in ChildrenPersistent AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

CompletedNCT00567476

Start: 2007-11-30End: 2010-04-30Updated: 2011-06-30

Unknown Phase

Asthma Research in Children and Adolescents

Active, not recruitingNCT04480242

Parc de Salut MarAsthma Exacerbation, Asthma in Children, Persistent Asthma

Start: 2017-07-26End: 2030-12-31Target: 525Updated: 2025-07-31

Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

CompletedNCT05402020

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2022-09-30End: 2023-02-13Updated: 2024-08-09

Exacerbation Risk in Asthma

CompletedNCT05501639

Boehringer IngelheimAsthma

Start: 2021-05-14End: 2021-11-02Updated: 2024-04-01

Related Papers

Impact of treatment adherence and inhalation technique on asthma outcomes of pediatric patients: a longitudinal study

Frontiers in Pharmacology2024-03-136 citations

Asthma bronchiale bei Kindern und Jugendlichen: Therapieadhärenz und Inhalationstechnik beeinflussen das klinische Outcome

Kompass Pneumologie2024-01-01